Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
640 | 3219 | 51.2 | 94% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
441 | 3 | TRAIL//SURVIVIN//APOPTOSIS | 26474 |
306 | 2 | TRAIL//SURVIVIN//APOPTOSIS | 18497 |
640 | 1 | MCL 1//BCL 2 FAMILY//BH3 MIMETIC | 3219 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MCL 1 | authKW | 764786 | 7% | 36% | 224 |
2 | BCL 2 FAMILY | authKW | 444179 | 5% | 28% | 165 |
3 | BH3 MIMETIC | authKW | 421632 | 2% | 65% | 68 |
4 | ABT 737 | authKW | 408742 | 2% | 57% | 76 |
5 | BH3 ONLY | authKW | 266197 | 1% | 70% | 40 |
6 | BAK | authKW | 265905 | 3% | 30% | 94 |
7 | BCL 2 | authKW | 228895 | 13% | 6% | 424 |
8 | BH3 ONLY PROTEINS | authKW | 224202 | 2% | 46% | 51 |
9 | BAX | authKW | 224025 | 9% | 9% | 277 |
10 | BH3 | authKW | 223123 | 1% | 59% | 40 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 17213 | 38% | 0% | 1216 |
2 | Biochemistry & Molecular Biology | 9210 | 45% | 0% | 1456 |
3 | Oncology | 7043 | 25% | 0% | 818 |
4 | Hematology | 922 | 6% | 0% | 191 |
5 | Biophysics | 709 | 6% | 0% | 207 |
6 | Genetics & Heredity | 544 | 7% | 0% | 219 |
7 | Chemistry, Medicinal | 409 | 4% | 0% | 132 |
8 | Medicine, Research & Experimental | 120 | 4% | 0% | 113 |
9 | Developmental Biology | 72 | 1% | 0% | 43 |
10 | Immunology | 62 | 4% | 0% | 132 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL GENET CANC | 68901 | 1% | 28% | 26 |
2 | TEAM CELL SURVIVAL TUMOR ESC E BREAST CANC 8 | 50577 | 0% | 67% | 8 |
3 | UMR601 | 46468 | 0% | 70% | 7 |
4 | PROGRAM CANC CHEM BIOL | 34825 | 0% | 28% | 13 |
5 | SERONO PHARMACEUT | 33737 | 0% | 32% | 11 |
6 | PLATEFORME IMPACT | 25288 | 0% | 67% | 4 |
7 | WALTER ELIZA HALL MED | 24484 | 2% | 4% | 60 |
8 | BIOGENOUEST RECH THER EUT | 21338 | 0% | 75% | 3 |
9 | LINDE PROGRAM CANC CHEM BIOL | 20076 | 0% | 35% | 6 |
10 | EQUIPE ELISEE LIGUE 5 | 18968 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELL DEATH AND DIFFERENTIATION | 67330 | 5% | 5% | 150 |
2 | CELL DEATH & DISEASE | 17964 | 2% | 3% | 67 |
3 | PEZCOLLER FOUNDATION SYMPOSIA | 13118 | 2% | 3% | 53 |
4 | ONCOGENE | 7782 | 4% | 1% | 123 |
5 | JOURNAL OF BIOLOGICAL CHEMISTRY | 3709 | 8% | 0% | 254 |
6 | MOLECULAR CANCER THERAPEUTICS | 3481 | 1% | 1% | 39 |
7 | MOLECULAR CELL | 2713 | 1% | 1% | 40 |
8 | APOPTOSIS | 2518 | 0% | 4% | 6 |
9 | BLOOD | 2143 | 3% | 0% | 91 |
10 | CANCER CELL | 1763 | 1% | 1% | 17 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MCL 1 | 764786 | 7% | 36% | 224 | Search MCL+1 | Search MCL+1 |
2 | BCL 2 FAMILY | 444179 | 5% | 28% | 165 | Search BCL+2+FAMILY | Search BCL+2+FAMILY |
3 | BH3 MIMETIC | 421632 | 2% | 65% | 68 | Search BH3+MIMETIC | Search BH3+MIMETIC |
4 | ABT 737 | 408742 | 2% | 57% | 76 | Search ABT+737 | Search ABT+737 |
5 | BH3 ONLY | 266197 | 1% | 70% | 40 | Search BH3+ONLY | Search BH3+ONLY |
6 | BAK | 265905 | 3% | 30% | 94 | Search BAK | Search BAK |
7 | BCL 2 | 228895 | 13% | 6% | 424 | Search BCL+2 | Search BCL+2 |
8 | BH3 ONLY PROTEINS | 224202 | 2% | 46% | 51 | Search BH3+ONLY+PROTEINS | Search BH3+ONLY+PROTEINS |
9 | BAX | 224025 | 9% | 9% | 277 | Search BAX | Search BAX |
10 | BH3 | 223123 | 1% | 59% | 40 | Search BH3 | Search BH3 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CZABOTAR, PE , LESSENE, G , STRASSER, A , ADAMS, JM , (2014) CONTROL OF APOPTOSIS BY THE BCL-2 PROTEIN FAMILY: IMPLICATIONS FOR PHYSIOLOGY AND THERAPY.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 15. ISSUE 1. P. 49 -63 | 157 | 74% | 433 |
2 | YOULE, RJ , STRASSER, A , (2008) THE BCL-2 PROTEIN FAMILY: OPPOSING ACTIVITIES THAT MEDIATE CELL DEATH.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 9. ISSUE 1. P. 47 -59 | 108 | 67% | 2030 |
3 | DELBRIDGE, ARD , GRABOW, S , STRASSER, A , VAUX, DL , (2016) THIRTY YEARS OF BCL-2: TRANSLATING CELL DEATH DISCOVERIES INTO NOVEL CANCER THERAPIES.NATURE REVIEWS CANCER. VOL. 16. ISSUE 2. P. 99 -109 | 116 | 63% | 16 |
4 | WESTPHAL, D , KLUCK, RM , DEWSON, G , (2014) BUILDING BLOCKS OF THE APOPTOTIC PORE: HOW BAX AND BAK ARE ACTIVATED AND OLIGOMERIZE DURING APOPTOSIS.CELL DEATH AND DIFFERENTIATION. VOL. 21. ISSUE 2. P. 196-205 | 102 | 86% | 63 |
5 | SHAMAS-DIN, A , KALE, J , LEBER, B , ANDREWS, DW , (2013) MECHANISMS OF ACTION OF BCL-2 FAMILY PROTEINS.COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY. VOL. 5. ISSUE 4. P. - | 103 | 82% | 86 |
6 | SIDDIQUI, WA , AHAD, A , AHSAN, H , (2015) THE MYSTERY OF BCL2 FAMILY: BCL-2 PROTEINS AND APOPTOSIS: AN UPDATE.ARCHIVES OF TOXICOLOGY. VOL. 89. ISSUE 3. P. 289 -317 | 137 | 53% | 40 |
7 | BHOLA, PD , LETAI, A , (2016) MITOCHONDRIA-JUDGES AND EXECUTIONERS OF CELL DEATH SENTENCES.MOLECULAR CELL. VOL. 61. ISSUE 5. P. 695 -704 | 85 | 66% | 16 |
8 | LEVERSON, JD , ZHANG, H , CHEN, J , TAHIR, SK , PHILLIPS, DC , XUE, J , NIMMER, P , JIN, S , SMITH, M , XIAO, Y , ET AL (2015) POTENT AND SELECTIVE SMALL-MOLECULE MCL-1 INHIBITORS DEMONSTRATE ON-TARGET CANCER CELL KILLING ACTIVITY AS SINGLE AGENTS AND IN COMBINATION WITH ABT-263 (NAVITOCLAX).CELL DEATH & DISEASE. VOL. 6. ISSUE . P. - | 59 | 89% | 75 |
9 | ROY, MJ , VOM, A , CZABOTAR, PE , LESSENE, G , (2014) CELL DEATH AND THE MITOCHONDRIA: THERAPEUTIC TARGETING OF THE BCL-2 FAMILY-DRIVEN PATHWAY.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 171. ISSUE 8. P. 1973-1987 | 107 | 79% | 26 |
10 | SHAMAS-DIN, A , BRAHMBHATT, H , LEBER, B , ANDREWS, DW , (2011) BH3-ONLY PROTEINS: ORCHESTRATORS OF APOPTOSIS.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. VOL. 1813. ISSUE 4. P. 508-520 | 110 | 76% | 95 |
Classes with closest relation at Level 1 |